The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of risk stratification using blood biochemical parameters in Japanese patients with metastatic renal cell carcinoma treated by nivolumab.
 
Yoshiaki Yamamoto
No Relationships to Disclose
 
Hideyasu Matsuyama
Honoraria - AstraZeneca; Bayer; Janssen; MSD; Sanofi
Consulting or Advisory Role - Janssen; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Janssen (Inst); MSD Oncology (Inst); Pfizer (Inst)
 
Hiroaki Matsumoto
No Relationships to Disclose
 
Shigeru Sakano
No Relationships to Disclose
 
Nakanori Fujii
No Relationships to Disclose
 
Kazuo Oba
No Relationships to Disclose
 
Mitsutaka Yamamoto
No Relationships to Disclose
 
Yoriaki Kamiryo
No Relationships to Disclose
 
Takeshi Hiragino
No Relationships to Disclose
 
Kazuhiro Nagao
No Relationships to Disclose
 
Kimio Takai
No Relationships to Disclose
 
Akihiko Aoki
No Relationships to Disclose
 
Satoru Yoshihiro
No Relationships to Disclose
 
Manabu Tsukamoto
No Relationships to Disclose
 
Jumpei Akao
No Relationships to Disclose
 
Seiji Kitahara
No Relationships to Disclose
 
Taku Misumi
No Relationships to Disclose
 
Hirotaka Komatsu
No Relationships to Disclose
 
Shintaro Oka
No Relationships to Disclose
 
Akinobu Suga
No Relationships to Disclose